Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Dollinger

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 1, 1997
Peripheral eosinophil count both before and after liver transplantation predicts acute cellular rejectionM M Dollinger, J N Plevris, I A Bouchier, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 26, 1998
Intrahepatic proliferation of 'naive' and 'memory' T cells during liver allograft rejection: primary immune response within the allograftM M Dollinger, S E Howie, J N Plevris, et al.
Journal of Hepatology|February 2, 1999
Indocyanine green clearance reflects reperfusion injury following liver transplantation and is an early predictor of graft functionJ N Plevris, R Jalan, K I Bzeizi, et al.
Zeitschrift Fur Gastroenterologie|February 7, 2008
Course of Crohn's disease prior to establishment of the diagnosisJ G Albert, J Kotsch, W Köstler, et al.
British Journal of Cancer|March 19, 2009
Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II studyF Kullmann, S Hollerbach, M M Dollinger, et al.
Gut|November 22, 2008
Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivoH Aurich, M Sgodda, P Kaltwasser, et al.
Oncology|September 7, 2011
KRAS mutation in metastatic pancreatic ductal adenocarcinoma: results of a multicenter phase II study evaluating efficacy of cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line therapyF Kullmann, A Hartmann, R Stöhr, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programmeM Moehler, A Maderer, C Schimanski, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 1, 1997
Peripheral eosinophil count both before and after liver transplantation predicts acute cellular rejectionM M Dollinger, J N Plevris, I A Bouchier, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 26, 1998
Intrahepatic proliferation of 'naive' and 'memory' T cells during liver allograft rejection: primary immune response within the allograftM M Dollinger, S E Howie, J N Plevris, et al.
Journal of Hepatology|February 2, 1999
Indocyanine green clearance reflects reperfusion injury following liver transplantation and is an early predictor of graft functionJ N Plevris, R Jalan, K I Bzeizi, et al.
Zeitschrift Fur Gastroenterologie|February 7, 2008
Course of Crohn's disease prior to establishment of the diagnosisJ G Albert, J Kotsch, W Köstler, et al.
British Journal of Cancer|March 19, 2009
Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II studyF Kullmann, S Hollerbach, M M Dollinger, et al.
Gut|November 22, 2008
Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivoH Aurich, M Sgodda, P Kaltwasser, et al.
Oncology|September 7, 2011
KRAS mutation in metastatic pancreatic ductal adenocarcinoma: results of a multicenter phase II study evaluating efficacy of cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line therapyF Kullmann, A Hartmann, R Stöhr, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programmeM Moehler, A Maderer, C Schimanski, et al.
Pageof 2